← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2013Last known activity
Aug 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT04983667Lead sponsorN/AAug 1, 2021
- NCT04983667Reponsible party - principal investigatorN/AAug 1, 2021
- NCT02087683Lead sponsorN/ANov 30, 2014
- NCT02087683Overall official - principal investigatorN/ANov 30, 2014
- NCT02087683Reponsible party - principal investigatorN/ANov 30, 2014
- NCT01929551Sponsor investigatorN/AAug 31, 2013
- NCT01929551Reponsible party - principal investigatorN/AAug 31, 2013
- NCT01929551Lead sponsorN/AAug 31, 2013
- NCT01909336Reponsible party - principal investigatorPhase 3Jul 1, 2013
- NCT01909336Lead sponsorPhase 3Jul 1, 2013
Details
- Last known activity
- Aug 1, 2021